Published in
Elsevier, Revista Colombiana de Cardiología, 1(22), p. 27-37, 2015
DOI: 10.1016/j.rccar.2014.10.004
Links
Tools
Guía basada en la evidencia para el manejo perioperatorio de la anticoagulación oral con warfarina en pacientes con alto riesgo embólico que serán llevados a implante de dispositivos de estimulación cardiaca
Journal article published in 2015 by
Alejandro Olaya,
Hernán Calvo,
Catalina Pinzón,
Magda Alba,
Magda Cepeda,
John Liévano,
María H. Solano,
Guillermo Mora
This paper is made freely available by the publisher.
Full text: Download
Postprint:
archiving forbidden
Published version:
archiving forbidden
Data provided by 
Abstract
The perioperative management of chronic anticoagulation concerns all physicians involved in the implantation of cardiac electronic devices (either pacemakers and cardioverter-defibrillators). Switching from warfarin to low molecular weight heparins (LMWH) has been performed to reduce the risk of bleeding. However, this approach has been shown to be controversial.